|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 413 NORTH LEE STREET |
Address2 | P.O. BOX 1417-DR49 |
City | ALEXANDRIA |
State | VA |
Zip Code | 22313 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 26672-12
|
||||||||
|
6. House ID# 302390000
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: R. James Huber, Executive Vice President and CFO |
Date | 10/19/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
H.R.3590, Patient Protection and Affordable Care Act
H.R.4872, Reconciliation Act of 2010
H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements.
S.525, Pharmaceutical Market Access Act
S.1232, Pharmaceutical Market Access and Drug Safety Act
H.R.1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations.
H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program.
H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program.
H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs.
S.256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine.
S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements.
H.R.2221, Data Accountability and Trust Act, as related to provider privacy requirements.
H.R.4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP.
S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds.
S.3543, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010.
H.R.5136, National Defense Authorization Act for Fiscal Year 2011.
S.3454, National Defense Authorization Act for Fiscal Year 2011.
H.R.5235, Medicare Access to Diabetes Supplies Act.
S.80, Pharmaceutical Market ccess Act of 2009.
S.511, Access to Durable Medical Equipment Act
S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steve |
Anderson |
|
|
|
Yong |
Choe |
|
|
|
Diane |
Darvey |
|
|
|
Anne |
Foley |
|
|
|
Carol |
Kelly |
|
|
|
Paul |
Kelly |
|
|
|
Julie |
Khani |
|
|
|
Kevin |
Nicholson |
|
|
|
Marc |
Schloss |
|
|
|
Heidi |
Ecker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
H.R. 1173, the Organized Retail Crime Act of 2008, as related to the prosecution of organized theft.
H.R.1166, the E-fencing Enforcement Act of 2008, as related to the prosecution of organized theft.
H.R.4011, Organized Retail Crime Prevention and Enforcement Act of 2009, as related to the prosecution of organized theft.
S.470, Combating Organized etail Crime Act of 2009, as related to the prosecution of organized theft.
H.R.5710, The National All Schedules Electronic Reporting Reauthorization Act.
S.3397, Secure and Responsible Drug Disposal Act.
H.R.1191, Safe Drug Disposal Act.
H.R.5932, Organized Retail Theft Investigation and Prosecution Act.
S.3575, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steve |
Anderson |
|
|
|
Yong |
Choe |
|
|
|
Anne |
Foley |
|
|
|
Carol |
Kelly |
|
|
|
Paul |
Kelly |
|
|
|
Julie |
Khani |
|
|
|
Kevin |
Nicholson |
|
|
|
Marc |
Schloss |
|
|
|
Heidi |
Ecker |
|
|
|
Diane |
Darvey |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |